The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Interferons Regulate the Phenotype of Wild-type and Mutant Herpes Simplex Viruses In Vivo
Open accessAbstract
Mechanisms responsible for neuroattenuation of herpes simplex virus (HSV) have been defined previously by studies of mutant viruses in cultured cells. The hypothesis that null mutations in host genes can override the attenuated phenotype of null mutations in certain viral genes was tested. Mutants such as those in infected cell protein (ICP) 0, thymidine kinase, ribonucleotide reductase, virion host shutoff, and ICP34.5 are reduced in their capacity to replicate in nondividing cells in culture and in vivo. The replication of these viruses was examined in eyes and trigeminal ganglia for 1–7 d after corneal inoculation in mice with null mutations (−/−) in interferon receptors (IFNR) for type I IFNs (IFN-α/βR), type II IFN (IFN-γR), and both type I and type II IFNs (IFN-α/β/γR). Viral titers in eyes and ganglia of IFN-γR−/− mice were not significantly different from congenic controls. However, in IFN-α/βR−/− or IFN-α/β/γR−/− mice, growth of all mutants, including those with significantly impaired growth in cell culture, was enhanced by up to 1,000-fold in eyes and trigeminal ganglia. Blepharitis and clinical signs of infection were evident in IFN-α/βR−/− and IFN-α/β/γR−/− but not control mice for all viruses. Also, IFNs were shown to significantly reduce productive infection of, and spread from intact, but not scarified, corneas. Particularly striking was restoration of near-normal trigeminal ganglion replication and neurovirulence of an ICP34.5 mutant in IFN-α/βR−/− mice. These data show that IFNs play a major role in limiting mutant and wild-type HSV replication in the cornea and in the nervous system. In addition, the in vivo target of ICP34.5 may be host IFN responses. These experiments demonstrate an unsuspected role for host factors in defining the phenotypes of some HSV mutants in vivo. The phenotypes of mutant viruses therefore cannot be interpreted based solely upon studies in cell culture but must be considered carefully in the context of host factors that may define the in vivo phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Functional Role of Type I and Type II Interferons in Antiviral Defense
Müller, U., Steinhoff, U., Reis, L. F. L., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., & Aguet, M. (1994) · Science · doi:10.1126/science.8009221 · Cited by 2,453
Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas
Mineta, T., Rabkin, S. D., Yazaki, T., Hunter, W. D., & Martuza, R. L. (1995) · Nature Medicine · doi:10.1038/nm0995-938 · Cited by 822
Chou, J., Kern, E. R., Whitley, R. J., & Roizman, B. (1990) · Science · doi:10.1126/science.2173860 · Cited by 711
Genetic maps: locus maps of complex genomes
(1990) · Choice Reviews Online · doi:10.5860/choice.28-0952 · Cited by 420
Stow, N. D., & Stow, E. C. (1986) · Journal of General Virology · doi:10.1099/0022-1317-67-12-2571 · Cited by 415
Goldstein, D. J., & Weller, S. K. (1988) · Journal of Virology · doi:10.1128/jvi.62.1.196-205.1988 · Cited by 392
Everett, R. D. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02270.x · Cited by 390
Leib, D. A., Coen, D. M., Bogard, C. L., Hicks, K. A., Yager, D. R., Knipe, D. M., Tyler, K. L., & Schaffer, P. A. (1989) · Journal of Virology · doi:10.1128/jvi.63.2.759-768.1989 · Cited by 367
Self-citationCoen, D. M., Kosz-Vnenchak, M., Jacobson, J. G., Leib, D. A., Bogard, C. L., Schaffer, P. A., Tyler, K. L., & Knipe, D. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.12.4736 · Cited by 362
Self-citationThe pathogenicity of thymidine kinase-deficient mutants of herpes simplex virus in mice
Field, H. J., & Wildy, P. (1978) · Journal of Hygiene · doi:10.1017/s0022172400025109 · Cited by 334
Sacks, W. R., & Schaffer, P. A. (1987) · Journal of Virology · doi:10.1128/jvi.61.3.829-839.1987 · Cited by 328
Maul, G. G., Guldner, H. H., & Spivack, J. G. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-12-2679 · Cited by 315
Read, G. S., & Frenkel, N. (1983) · Journal of Virology · doi:10.1128/jvi.46.2.498-512.1983 · Cited by 290
Chou, J., Chen, J. J., Gross, M., & Roizman, B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.23.10516 · Cited by 284
O'Hare, P., & Hayward, G. S. (1985) · Journal of Virology · doi:10.1128/jvi.56.3.723-733.1985 · Cited by 279
Gelman, I. H., & Silverstein, S. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.16.5265 · Cited by 263
Perng, G. C., Dunkel, E. C., Geary, P. A., Slanina, S. M., Ghiasi, H., Kaiwar, R., Nesburn, A. B., & Wechsler, S. L. (1994) · Journal of Virology · doi:10.1128/jvi.68.12.8045-8055.1994 · Cited by 260
Kramer, M. F., & Coen, D. M. (1995) · Journal of Virology · doi:10.1128/jvi.69.3.1389-1399.1995 · Cited by 232
Jacobson, J. G., Leib, D. A., Goldstein, D. J., Bogard, C. L., Schaffer, P. A., Weller, S. K., & Coen, D. M. (1989) · Virology · doi:10.1016/0042-6822(89)90244-4 · Cited by 227
Self-citationCantin, E. M., Hinton, D. R., Chen, J., & Openshaw, H. (1995) · Journal of Virology · doi:10.1128/jvi.69.8.4898-4905.1995 · Cited by 227
Goldstein, D. J., & Weller, S. K. (1988) · Virology · doi:10.1016/0042-6822(88)90144-4 · Cited by 226
Relationship Between the Envelope and the Infectivity of Herpes Simplex Virus.
Smith, K. O. (1964) · Experimental Biology and Medicine · doi:10.3181/00379727-115-29045 · Cited by 223
Goldsmith, K., Chen, W., Johnson, D. C., & Hendricks, R. L. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.3.341 · Cited by 206
Samaniego, L. A., Wu, N., & DeLuca, N. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.6.4614-4625.1997 · Cited by 189
Biochemical Studies on the Herpes Simplex Virus-specified Deoxypyrimidine Kinase Activity
Jamieson, A. T., & Subak-Sharpe, J. H. (1974) · Journal of General Virology · doi:10.1099/0022-1317-24-3-481 · Cited by 177
Lees-Miller, S. P., Long, M. C., Kilvert, M. A., Lam, V, Rice, S. A., & Spencer, C. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7471-7477.1996 · Cited by 176
Heise, M. T., & Virgin, H. W. (1995) · Journal of Virology · doi:10.1128/jvi.69.2.904-909.1995 · Cited by 168
Self-citationRole of the virion host shutoff (vhs) of herpes simplex virus type 1 in latency and pathogenesis
Strelow, L. I., & Leib, D. A. (1995) · Journal of Virology · doi:10.1128/jvi.69.11.6779-6786.1995 · Cited by 158
Self-citationBolovan, C. A., Sawtell, N. M., & Thompson, R. (1994) · Journal of Virology · doi:10.1128/jvi.68.1.48-55.1994 · Cited by 153
Tigges, M. A., Leng, S. X., Johnson, D. C., & Burke, R. L. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.10.3901 · Cited by 141
He, B., Chou, J., Liebermann, D. A., Hoffman‐Liebermann, B., & Roizman, B. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.84-90.1996 · Cited by 140
Bouley, D. M., Kanangat, S., Wire, W. S., & Rouse, B. T. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.8.3964 · Cited by 137
Cai, W., & Schaffer, P. A. (1991) · Journal of Virology · doi:10.1128/jvi.65.8.4078-4090.1991 · Cited by 124
Interferon-γ Protects against Herpes Simplex Virus Type 1-Mediated Neuronal Death
Geiger, K. D., Nash, T. C., Sawyer, S. P., et al. (1997) · Virology · doi:10.1006/viro.1997.8841 · Cited by 103
Rader, K., Ackland-Berglund, C. E., Miller, J. K., Pepose, J. S., & Leib, D. A. (1993) · Journal of General Virology · doi:10.1099/0022-1317-74-9-1859 · Cited by 96
Self-citationThe Pathogenicity of Ribonucleotide Reductase-Null Mutants of Herpes Simplex Virus Type 1 in Mice
Yamada, Y., Kimura, H., Morishima, T., Daikoku, T., Maeno, K., & Nishiyama, Y. (1991) · The Journal of Infectious Diseases · doi:10.1093/infdis/164.6.1091 · Cited by 86
Jordan, R., & Schaffer, P. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.6850-6862.1997 · Cited by 85
Oberman, F., & Panet, A. (1988) · Journal of General Virology · doi:10.1099/0022-1317-69-6-1167 · Cited by 73
Bukowski, J. F., & Welsh, R. M. (1986) · The Journal of Immunology · doi:10.4049/jimmunol.136.9.3481 · Cited by 72
The herpes simplex virus type 1 strain 17+ 34.5 deletion mutant 1716 is avirulent in SCID mice
Vályi-Nagy, T., Fareed, M. U., O’Keefe, S. J., Gesser, R., MacLean, A. R., Brown, S. M., Spivack, J. G., & Fraser, N. (1994) · Journal of General Virology · doi:10.1099/0022-1317-75-8-2059 · Cited by 56
McKie, E. A., Graham, D. I., & Brown, S. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300621 · Cited by 42
Reactivation of thymidine kinase-defective herpes simplex virus is enhanced by nucleoside
Tenser, R. B., Gaydos, A., & Hay, K. A. (1996) · Journal of Virology · doi:10.1128/jvi.70.2.1271-1276.1996 · Cited by 18
Cited by
Autophagy and Viruses: Adversaries or Allies?
Dong, X., & Levine, B. (2013) · Journal of Innate Immunity · doi:10.1159/000346388 · Cited by 4,430
Noncytolytic Control of Viral Infections by the Innate and Adaptive ImmuneResponse
Guidotti, L. G., & Chisari, F. V. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.65 · Cited by 996
Impaired response to interferon-α/β and lethal viral disease in human STAT1 deficiency
Dupuis, S., Jouanguy, E., Al-Hajjar, S., Fieschi, C., Al-Mohsen, I. Z., Al-Jumaah, S., Yang, K., Chapgier, A., Eidenschenk, C., Eid, P., et al. (2003) · Nature Genetics · doi:10.1038/ng1097 · Cited by 816
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., & Colonna, M. (2004) · Blood · doi:10.1182/blood-2003-08-2674 · Cited by 695
Self-citationThe Virome in Mammalian Physiology and Disease
Virgin, H. W. (2014) · Cell · doi:10.1016/j.cell.2014.02.032 · Cited by 597
Self-citation
Metadata
- Authors
- Leib, D. A., Harrison, T. E., Laslo, K. M., Machalek, M. A., Moorman, N. J., & Virgin, H. W.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-02-15
- Volume
- 189
- Issue
- 4
- Pages
- 663-672
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2134321753
- Cited by
- 341
- References
- 42
- FWCI
- 12.50
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.